In Vitro Neutrophil Migration Requires Protein Kinase C-Delta (δ-PKC)-Mediated Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Phosphorylation

Inflammation

Volumn 38, Issue 3, 2015, Pages 1126-1141

  Sheats, Mary K ^a   Sung, Eui Jae ^a   Adler, Kenneth B ^a   Jones, Samuel L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

adhesion; chemotaxis; innate immunity; migration; neutrophil; PKC signaling

Indexed keywords

INTERLEUKIN 8; LEUKOTRIENE B4; MARCKS PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C ZETA; ROTTLERIN; ACETOPHENONE DERIVATIVE; BENZOPYRAN DERIVATIVE; ENZYME INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; ISOPROTEIN; MEMBRANE PROTEIN; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE; SIGNAL PEPTIDE;

ADULT; ARTICLE; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PROTEIN PHOSPHORYLATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION;

ACETOPHENONES; BENZOPYRANS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN KINASE C-DELTA;

EID: 84928882139     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0078-9     Document Type: Article

References (82)

1. Malech, H.L., and J.I. Gallin. 1987. Current concepts: immunology. Neutrophils in human diseases. New England Journal of Medicine 317(11): 687–694.
2. Segel, G.B., M.W. Halterman, and M.A. Lichtman. 2011. The paradox of the neutrophil’s role in tissue injury. Journal of Leukocyte Biology 89(3): 359–372.
3. Gaestel, M., A. Kotlyarov, and M. Kracht. 2009. Targeting innate immunity protein kinase signaling in inflammation. Nature Reviews Drug Discovery 8(6): 480–499.
4. Cohen, P. 2009. Targeting protein kinases for the development of anti-inflammatory drugs. Current Opinion in Cell Biology 21(2): 317–324.
5. Bertram, A., and K. Ley. 2011. Protein kinase C isoforms in neutrophil adhesion and activation. Archivum Immunologiae et Therapiae Experimentalis (Warsz) 59(2): 79–87.
6. Kilpatrick, L.E., J.Y. Lee, K.M. Haines, D.E. Campbell, K.E. Sullivan, and H.M. Korchak. 2002. A role for PKC-delta and PI 3-kinase in TNF-alpha-mediated antiapoptotic signaling in the human neutrophil. American Journal of Physiology - Cellular Physiology 283(1): C48–C57.
7. Ramnath, R.D., J. Sun, and M. Bhatia. 2010. PKC delta mediates pro-inflammatory responses in a mouse model of caerulein-induced acute pancreatitis. Journal of Molecular Medicine (Berl) 88(10): 1055–1063.
8. Page, K., J. Li, L. Zhou, S. Lasvovskaia, K.C. Corbit, J.W. Soh, et al. 2003. Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta. Journal of Immunology 170(11): 5681–5689.
9. Kilpatrick, L.E., S. Sun, H. Li, T.C. Vary, and H.M. Korchak. 2010. Regulation of TNF-induced oxygen radical production in human neutrophils: Role of delta-PKC. Journal of Leukocyte Biology 87(1): 153–164.
10. Mondrinos, M.J., T. Zhang, S. Sun, P.A. Kennedy, D.J. King, M.R. Wolfson, et al. 2014. Pulmonary endothelial protein kinase C-delta (PKC delta) regulates neutrophil migration in acute lung inflammation. American Journal of Pathology 184(1): 200–213.
11. Kilpatrick, L.E., S.W. Standage, H. Li, N.R. Raj, H.M. Korchak, M.R. Wolfson, et al. 2011. Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-delta (delta-PKC). Journal of Leukocyte Biology 89(1): 3–10.
12. Eckert, R.E., L.E. Neuder, J. Park, K.B. Adler, and S.L. Jones. 2010. Myristoylated alanine-rich C-kinase substrate (MARCKS) protein regulation of human neutrophil migration. American Journal of Respiratory Cell and Molecular Biology 42(5): 586–594.
13. Takashi, S., J. Park, S. Fang, S. Koyama, I. Parikh, and K.B. Adler. 2006. A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate inhibits degranulation of human leukocytes in vitro. American Journal of Respiratory Cell and Molecular Biology 34(6): 647–652.
14. Sheats, M.K., K.C. Pescosolido, E.M. Hefner, E.J. Sung, K.B. Adler, and S.L. Jones. 2014. Myristoylated alanine rich C kinase substrate (MARCKS) is essential to beta2-integrin dependent responses of equine neutrophils. Veterinary Immunology and Immunopathology 160(3–4): 167–176.
15. Thelen, M., A. Rosen, A.C. Nairn, and A. Aderem. 1990. Tumor necrosis factor alpha modifies agonist-dependent responses in human neutrophils by inducing the synthesis and myristoylation of a specific protein kinase C substrate. Proceedings of the National Academy of Sciences of the United States of America 87(15): 5603–5607.
16. Thelen, M., A. Rosen, A.C. Nairn, and A. Aderem. 1991. Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature 351(6324): 320–322.
17. Arbuzova, A., A.A. Schmitz, and G. Vergeres. 2002. Cross-talk unfolded: MARCKS proteins. Biochemistry Journal 362(Pt 1): 1–12.
18. Nairn, A.C., and A. Aderem. 1992. Calmodulin and protein kinase C cross-talk: the MARCKS protein is an actin filament and plasma membrane cross-linking protein regulated by protein kinase C phosphorylation and by calmodulin. Ciba Foundation Symposium 164: 145–154. discussion 154–61.
19. Hartwig, J.H., M. Thelen, A. Rosen, P.A. Janmey, A.C. Nairn, and A. Aderem. 1992. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 356(6370): 618–622.
20. Blackshear, P.J. 1993. The MARCKS family of cellular protein kinase C substrates. Journal of Biological Chemistry 268(3): 1501–1504.
21. Aderem, A. 1992. The MARCKS brothers: a family of protein kinase C substrates. Cell 71(5): 713–716.
22. Aderem, A. 1992. Signal transduction and the actin cytoskeleton: the roles of MARCKS and profilin. Trends in Biochemical Sciences 17(10): 438–443.
23. Futosi, K., S. Fodor, and A. Mocsai. 2013. Reprint of neutrophil cell surface receptors and their intracellular signal transduction pathways. International Immunopharmacology 17(4): 1185–1197.
24. Kent, J.D., S. Sergeant, D.J. Burns, and L.C. McPhail. 1996. Identification and regulation of protein kinase C-delta in human neutrophils. Journal of Immunology 157(10): 4641–4647.
25. Mochly-Rosen, D., C.J. Henrich, L. Cheever, H. Khaner, and P.C. Simpson. 1990. A protein kinase C isozyme is translocated to cytoskeletal elements on activation. Cellular Regulation 1(9): 693–706.
26. Disatnik, M.H., S.C. Boutet, W. Pacio, A.Y. Chan, L.B. Ross, C.H. Lee, et al. 2004. The bi-directional translocation of MARCKS between membrane and cytosol regulates integrin-mediated muscle cell spreading. Journal of Cell Science 117(Pt 19): 4469–4479.
27. Laudanna, C., D. Mochly-Rosen, T. Liron, G. Constantin, and E.C. Butcher. 1998. Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. Journal of Biological Chemistry 273(46): 30306–30315.
28. Schmidt, S., M. Moser, and M. Sperandio. 2013. The molecular basis of leukocyte recruitment and its deficiencies. Molecular Immunology 55(1): 49–58.
29. Xiao, H., and M. Liu. 2013. Atypical protein kinase C in cell motility. Cellular and Molecular Life Sciences 70(17): 3057–3066.
30. Hirai, T., and K. Chida. 2003. Protein kinase c zeta (PKC zeta): activation mechanisms and cellular functions. Journal of Biochemistry 133(1): 1–7.
31. Steinberg, S.F. 2008. Structural basis of protein kinase C isoform function. Physiological Reviews 88(4): 1341–1378.
32. Ono, Y., T. Fujii, K. Ogita, U. Kikkawa, K. Igarashi, and Y. Nishizuka. 1988. The structure, expression, and properties of additional members of the protein kinase C family. Journal of Biological Chemistry 263(14): 6927–6932.
33. Chou, M.M., W. Hou, J. Johnson, L.K. Graham, M.H. Lee, C.S. Chen, et al. 1998. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Current Biology 8(19): 1069–1077.
34. Balasubramanian, N., S.H. Advani, and S.M. Zingde. 1998. Protein kinase C isoforms in normal and chronic myeloid leukemic neutrophils. Distinct signal for PKC alpha by immunodetection on PVDF membrane, decreased expression of PKC alpha and increased expression of PKC delta in leukemic neutrophils. Leukemia Research 22(7): 597–604.
35. Smallwood, J.I., and S.E. Malawista. 1992. Protein kinase C isoforms in human neutrophil cytoplasts. Journal of Leukocyte Biology 51(1): 84–92.
36. Geraldes, P., and G.L. King. 2010. Activation of protein kinase C isoforms and its impact on diabetic complications. Circulation Research 106(8): 1319–1331.
37. Carpenter, A.C., and J.S. Alexander. 2008. Endothelial PKC delta activation attenuates neutrophil transendothelial migration. Inflammation Research 57(5): 216–229.
38. Fogh, B.S., H.A. Multhaupt, and J.R. Couchman. 2014. Protein kinase C, focal adhesions and the regulation of cell migration. Journal of Histochemistry and Cytochemistry 62(3): 172–184.
39. Gray, R.D., C.D. Lucas, A. Mackellar, F. Li, K. Hiersemenzel, C. Haslett, et al. 2013. Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps. Journal of Inflammation (Lond) 10(1): 12,9255. -10-12.
40. Larsson, C. 2006. Protein kinase C and the regulation of the actin cytoskeleton. Cellular Signalling 18(3): 276–284.
41. Park, J.A., A.L. Crews, W.R. Lampe, S. Fang, J. Park, and K.B. Adler. 2007. Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein. American Journal of Pathology 171(6): 1822–1830.
42. Ohkura, K., H. Hori, and H. Terada. 1998. Effect of extracellular calcium on the intracellular calcium level of newborn rat skin basal cells. Biological and Pharmaceutical Bulletin 21(1): 1–4.
43. Majumdar, S., M.W. Rossi, T. Fujiki, W.A. Phillips, S. Disa, C.F. Queen, et al. 1991. Protein kinase C isotypes and signaling in neutrophils. differential substrate specificities of a translocatable calcium- and phospholipid-dependent beta-protein kinase C and a phospholipid-dependent protein kinase which is inhibited by long chain fatty acyl coenzyme A. Journal of Biological Chemistry 266(14): 9285–9294.
44. Chou, W.H., D.S. Choi, H. Zhang, D. Mu, T. McMahon, V.N. Kharazia, et al. 2004. Neutrophil protein kinase Cdelta as a mediator of stroke-reperfusion injury. Journal of Clinical Investigation 114(1): 49–56.
45. Damera, G., W.F. Jester, M. Jiang, H. Zhao, H.W. Fogle, M. Mittelman, et al. 2010. Inhibition of myristoylated alanine-rich C kinase substrate (MARCKS) protein inhibits ozone-induced airway neutrophilia and inflammation. Experimental Lung Research 36(2): 75–84.
46. Foster, W.M., K.B. Adler, A.L. Crews, E.N. Potts, B.M. Fischer, and J.A. Voynow. 2010. MARCKS-related peptide modulates in vivo the secretion of airway Muc5ac. American Journal of Physiology - Lung Cellular and Molecular Physiology 299(3): L345–L352.
47. Li, J., M.A. D'Annibale-Tolhurst, K.B. Adler, S. Fang, Q. Yin, A.J. Birkenheuer, et al. 2013. A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils. American Journal of Respiratory Cell and Molecular Biology 48(3): 314–321.
48. Yue, L., S. Lu, J. Garces, T. Jin, and J. Li. 2000. Protein kinase C-regulated dynamitin-macrophage-enriched myristoylated alanine-rice C kinase substrate interaction is involved in macrophage cell spreading. Journal of Biological Chemistry 275(31): 23948–23956.
49. Myat, M.M., S. Anderson, L.A. Allen, and A. Aderem. 1997. MARCKS regulates membrane ruffling and cell spreading. Current Biology 7(8): 611–614.
50. Estrada-Bernal, A., J.C. Gatlin, S. Sunpaweravong, and K.H. Pfenninger. 2009. Dynamic adhesions and MARCKS in melanoma cells. Journal of Cell Science 122(Pt 13): 2300–2310.
51. Yamaguchi, H., M. Shiraishi, K. Fukami, A. Tanabe, Y. Ikeda-Matsuo, Y. Naito, et al. 2009. MARCKS regulates lamellipodia formation induced by IGF-I via association with PIP2 and beta-actin at membrane microdomains. Journal of Cellular Physiology 220(3): 748–755.
52. Kalwa, H., and T. Michel. 2011. The MARCKS protein plays a critical role in phosphatidylinositol 4,5-bisphosphate metabolism and directed cell movement in vascular endothelial cells. Journal of Biological Chemistry 286(3): 2320–2330.
53. Rosen, A., K.F. Keenan, M. Thelen, A.C. Nairn, and A. Aderem. 1990. Activation of protein kinase C results in the displacement of its myristoylated, alanine-rich substrate from punctate structures in macrophage filopodia. Journal of Experimental Medicine 172(4): 1211–1215.
54. Lee, S., E. Jang, J.H. Kim, J.H. Kim, W.H. Lee, and K. Suk. 2012. Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects. Journal of Biological Chemistry 287(12): 9414–9428.
55. Tanimukai, S., H. Hasegawa, M. Nakai, K. Yagi, M. Hirai, N. Saito, et al. 2002. Nanomolar amyloid beta protein activates a specific PKC isoform mediating phosphorylation of MARCKS in Neuro2A cells. Neuroreport 13(4): 549–553.
56. Chappell, D.S., N.A. Patel, K. Jiang, P. Li, J.E. Watson, D.M. Byers, et al. 2009. Functional involvement of protein kinase C-betaII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cells. Diabetologia 52(5): 901–911.
57. Siskova, Z., W. Baron, H. de Vries, and D. Hoekstra. 2006. Fibronectin impedes “myelin” sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking. Molecular and Cellular Neurosciences 33(2): 150–159.
58. Salli, U., N. Saito, and F. Stormshak. 2003. Spatiotemporal interactions of myristoylated alanine-rich C kinase substrate (MARCKS) protein with the actin cytoskeleton and exocytosis of oxytocin upon prostaglandin F2alpha stimulation of bovine luteal cells. Biology of Reproduction 69(6): 2053–2058.
59. Chen, X., and S.A. Rotenberg. 2010. PhosphoMARCKS drives motility of mouse melanoma cells. Cellular Signalling 22(7): 1097–1103.
60. Finlayson, A.E., and K.W. Freeman. 2009. A cell motility screen reveals role for MARCKS-related protein in adherens junction formation and tumorigenesis. PLoS One 4(11): e7833.
61. Uberall, F., S. Giselbrecht, K. Hellbert, F. Fresser, B. Bauer, M. Gschwendt, et al. 1997. Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3'T3 fibroblasts. Journal of Biological Chemistry 272(7): 4072–4078.
62. Song, J.C., B.J. Hrnjez, O.C. Farokhzad, and J.B. Matthews. 1999. PKC-epsilon regulates basolateral endocytosis in human T84 intestinal epithelia: role of F-actin and MARCKS. American Journal of Physiology 277(6 Pt 1): C1239–C1249.
63. Kim, S.S., J.H. Kim, H.S. Kim, D.E. Park, and C.H. Chung. 2000. Involvement of the theta-type protein kinase C in translocation of myristoylated alanine-rich C kinase substrate (MARCKS) during myogenesis of chick embryonic myoblasts. Biochemistry Journal 347(Pt 1): 139–146.
64. Dulong, S., S. Goudenege, K. Vuillier-Devillers, S. Manenti, S. Poussard, and P. Cottin. 2004. Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase calpha and calpain proteolytic cleavage. Biochemistry Journal 382(Pt 3): 1015–1023.
65. Sugiya, H., K. Satoh, M. Matsuki-Fukushima, B. Qi, M.Y. Guo, and J. Fujita-Yoshigaki. 2009. Role of protein kinase C-delta in isoproterenol-induced amylase release in rat parotid acinar cells. The Journal of Medical Investigation 56(Suppl): 368–370.
66. Gadi, D., A. Wagenknecht-Wiesner, D. Holowka, and B. Baird. 2011. Sequestration of phosphoinositides by mutated MARCKS effector domain inhibits stimulated ca (2+) mobilization and degranulation in mast cells. Molecular Biology of the Cell 22(24): 4908–4917.
67. Gschwendt, M., H.J. Muller, K. Kielbassa, R. Zang, W. Kittstein, G. Rincke, et al. 1994. Rottlerin, a novel protein kinase inhibitor. Biochemical and Biophysical Research Communications 199(1): 93–98.
68. Villalba, M., S. Kasibhatla, L. Genestier, A. Mahboubi, D.R. Green, and A. Altman. 1999. Protein kinase c theta cooperates with calcineurin to induce fas ligand expression during activation-induced T cell death. Journal of Immunology 163(11): 5813–5819.
69. Soltoff, S.P. 2007. Rottlerin: an inappropriate and ineffective inhibitor of PKC delta. Trends in Pharmacological Sciences 28(9): 453–458.
70. Wermuth, P.J., S. Addya, and S.A. Jimenez. 2011. Effect of protein kinase C delta (PKC-delta) inhibition on the transcriptome of normal and systemic sclerosis human dermal fibroblasts in vitro. PLoS One 6(11): e27110.
71. Hendey, B., C.L. Zhu, and S. Greenstein. 2002. Fas activation opposes PMA-stimulated changes in the localization of PKC delta: a mechanism for reducing neutrophil adhesion to endothelial cells. Journal of Leukocyte Biology 71(5): 863–870.
72. Pabla, N., G. Dong, M. Jiang, S. Huang, M.V. Kumar, R.O. Messing, et al. 2011. Inhibition of PKC delta reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer. Journal of Clinical Investigation 121(7): 2709–2722.
73. Yanase, N., M. Hayashida, Y. Kanetaka-Naka, A. Hoshika, and J. Mizuguchi. 2012. PKC-delta mediates interferon-alpha-induced apoptosis through c-jun NH(2)-terminal kinase activation. BMC Cell Biology 13(7): 2121–2137.
74. Chakrabarti, S., and K.D. Patel. 2008. The atypical zeta (zeta) isoform of protein kinase C regulates CD11b/CD18 activation in human neutrophils. Microcirculation 15(6): 555–567.
75. Dewald, B., M. Thelen, and M. Baggiolini. 1988. Two transduction sequences are necessary for neutrophil activation by receptor agonists. Journal of Biological Chemistry 263(31): 16179–16184.
76. Ohmori, S., N. Sakai, Y. Shirai, H. Yamamoto, E. Miyamoto, N. Shimizu, et al. 2000. Importance of protein kinase C targeting for the phosphorylation of its substrate, myristoylated alanine-rich C-kinase substrate. Journal of Biological Chemistry 275(34): 26449–26457.
77. Yang, L., and M. Glaser. 1996. Formation of membrane domains during the activation of protein kinase C. Biochemistry 35(44): 13966–13974.
78. Laux, T., K. Fukami, M. Thelen, T. Golub, D. Frey, and P. Caroni. 2000. GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. Journal of Cell Biology 149(7): 1455–1472.
79. McLaughlin, S., J. Wang, A. Gambhir, and D. Murray. 2002. PIP(2) and proteins: interactions, organization, and information flow. Annual Review of Biophysics and Biomolecular Structure 31: 151–175.
80. Wang, J., A. Arbuzova, G. Hangyas-Mihalyne, and S. McLaughlin. 2001. The effector domain of myristoylated alanine-rich C kinase substrate binds strongly to phosphatidylinositol 4,5-bisphosphate. Journal of Biological Chemistry 276(7): 5012–5019.
81. Glaser, M., S. Wanaski, C.A. Buser, V. Boguslavsky, W. Rashidzada, A. Morris, et al. 1996. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. Journal of Biological Chemistry 271(42): 26187–26193.
82. Nakanishi, H., K.A. Brewer, and J.H. Exton. 1993. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. Journal of Biological Chemistry 268(1): 13–16.